Royalty Pharma
RPRX
#737
Rank
NZ$59.44 B
Marketcap
NZ$102.88
Share price
-1.73%
Change (1 day)
70.37%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: NZ$59.44 Billion

As of August 2026 Royalty Pharma has a market cap of NZ$59.44 Billion. This makes Royalty Pharma the world's 737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$59.44 B50.53%
2025NZ$39.49 B48.01%
2024NZ$26.68 B0.19%
2023NZ$26.63 B-3%
2022NZ$27.45 B9.57%
2021NZ$25.05 B-6.93%
2020NZ$26.92 B

End of Day market cap according to different sources

On Aug 28th, 2026 the market cap of Royalty Pharma was reported to be:

NZ$59.15 Billion
by Nasdaq info icon info icon
NZ$59.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$329.03 B 453.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.770 T 2,878.98%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$2.82 B-95.24%๐Ÿ‡บ๐Ÿ‡ธ USA